Fochon Pharmaceuticals, Ltd. clinical trials
A subsidiary of Fosun Pharma
The registry lists 5 studies whose lead sponsor is Fochon Pharmaceuticals, Ltd.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 13, 2024.
Registry sponsor names on this page
- Fochon Pharmaceuticals, Ltd.5 studies
Something wrong with this grouping? Tell us on the Fosun Pharma page.
Studies
Recruiting first, then most recently updated. Showing 5 of 5. All Fosun Pharma studies →
- A Study of FCN-338 in Patients With Chronic CLL/SLLActive, not recruitingNCT04682808Phase 1
Sponsor listed in the registry: Fochon Pharmaceuticals, Ltd.
- A Safety and Tolerability Study of FCN-207 in Healthy VolunteersCompletedNCT04622124Phase 1
Sponsor listed in the registry: Fochon Pharmaceuticals, Ltd.
- Study of FCN-437c in Patients With Advanced Solid TumorsCompletedNCT03951116Phase 1
Sponsor listed in the registry: Fochon Pharmaceuticals, Ltd.
- Study of FCN-098 in Patients With Advanced Solid TumorStatus unknownNCT05212987Phase 1
Sponsor listed in the registry: Fochon Pharmaceuticals, Ltd.
- Study of FCN-011 in Patients With Advanced Solid Tumor(Phase I)and NTRK Fusion Positive Advanced Solid Tumor (Phase II)Status unknownNCT04687423Phase 1
Sponsor listed in the registry: Fochon Pharmaceuticals, Ltd.